<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6308204</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">30622492</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6308204</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fpsyg.2018.02586</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical characteristics among three groups.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p>Demographic and clinical characteristics among three groups.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Variables</th><th valign="top" align="center" rowspan="1" colspan="1">UD (<italic>n</italic> = 33)</th><th valign="top" align="center" rowspan="1" colspan="1">tBD (<italic>n</italic> = 33)</th><th valign="top" align="center" rowspan="1" colspan="1">HC (<italic>n</italic> = 36)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex (M/F)</td><td valign="top" align="center" rowspan="1" colspan="1">17/16</td><td valign="top" align="center" rowspan="1" colspan="1">17/16</td><td valign="top" align="center" rowspan="1" colspan="1">18/18</td><td valign="top" align="center" rowspan="1" colspan="1">0.941<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, y</td><td valign="top" align="center" rowspan="1" colspan="1">30.91 ± 8.28</td><td valign="top" align="center" rowspan="1" colspan="1">31.39 ± 8.30</td><td valign="top" align="center" rowspan="1" colspan="1">32.41 ± 8.86</td><td valign="top" align="center" rowspan="1" colspan="1">0.684<sup>b</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Education, y</td><td valign="top" align="center" rowspan="1" colspan="1">13.85 ± 3.02</td><td valign="top" align="center" rowspan="1" colspan="1">13.88 ± 2.79</td><td valign="top" align="center" rowspan="1" colspan="1">15.02 ± 2.26</td><td valign="top" align="center" rowspan="1" colspan="1">0.053<sup>b</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Onset age, y</td><td valign="top" align="center" rowspan="1" colspan="1">28.03 ± 8.97</td><td valign="top" align="center" rowspan="1" colspan="1">28.48 ± 9.29</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.840<sup>c</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total illness duration, mo</td><td valign="top" align="center" rowspan="1" colspan="1">33.64 ± 53.31</td><td valign="top" align="center" rowspan="1" colspan="1">40.50 ± 62.20</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.632<sup>c</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Current episode duration, mo</td><td valign="top" align="center" rowspan="1" colspan="1">7.55 ± 12.81</td><td valign="top" align="center" rowspan="1" colspan="1">4.92 ± 4.97</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.279<sup>c</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of episode</td><td valign="top" align="center" rowspan="1" colspan="1">1.82 ± 1.26</td><td valign="top" align="center" rowspan="1" colspan="1">2.09 ± 1.36</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.400<sup>c</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total score of HAMD-17</td><td valign="top" align="center" rowspan="1" colspan="1">20.76 ± 9.26</td><td valign="top" align="center" rowspan="1" colspan="1">22.27 ± 7.27</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.462<sup>c</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Family history of AD</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (12.1%)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.355<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chronicity</td><td valign="top" align="center" rowspan="1" colspan="1">5 (15.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (21.2%)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.751<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Refractory</td><td valign="top" align="center" rowspan="1" colspan="1">3 (9.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (9.1%)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.000<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Suicide attempt</td><td valign="top" align="center" rowspan="1" colspan="1">5 (15.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (33.3%)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.150<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diurnal depression variance</td><td valign="top" align="center" rowspan="1" colspan="1">15 (45.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (42.4%)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.000<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Treatment</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SSRI/SNRI</td><td valign="top" align="center" rowspan="1" colspan="1">20/13</td><td valign="top" align="center" rowspan="1" colspan="1">18/15</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.618<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stabilizer</td><td valign="top" align="center" rowspan="1" colspan="1">5 (15.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (27.3%)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.228<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">rTMS</td><td valign="top" align="center" rowspan="1" colspan="1">4 (12.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (12.1%)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.000<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MECT</td><td valign="top" align="center" rowspan="1" colspan="1">4 (12.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (18.2%)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.733<sup>a</sup></td></tr></tbody></table><table-wrap-foot><attrib><italic>UD, unipolar depression; tBD, transformed bipolar depression; HC, health control; HAMD, Hamilton Depression Rating Scale; AD, affective disorder; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and norepinephrine reuptake inhibitor; rTMS, repetitive transcranial magnetic stimulation; MECT, modified electroconvulsive therapy.</italic></attrib><attrib><italic><sup>a</sup>The P-value was obtained by two-tailed Pearson chi-square t-test.</italic></attrib><attrib><italic><sup>b</sup>Data presented as the range of minimum-maximum (mean ± SD). The P-value was obtained by one-way analysis of variance.</italic></attrib><attrib><italic><sup>c</sup>Data presented as the range of minimum-maximum (mean ± SD). The P-value was obtained by two-sample two-tailed t-test.</italic></attrib></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics among three groups.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left">Variables</th><th valign="top" align="center">UD (n = 33)</th><th valign="top" align="center">tBD (n = 33)</th><th valign="top" align="center">HC (n = 36)</th><th valign="top" align="center">P-value</th></tr></thead><tbody><tr><td valign="top" align="left">Sex (M/F)</td><td valign="top" align="center">17/16</td><td valign="top" align="center">17/16</td><td valign="top" align="center">18/18</td><td valign="top" align="center">0.941a</td></tr><tr><td valign="top" align="left">Age, y</td><td valign="top" align="center">30.91 ± 8.28</td><td valign="top" align="center">31.39 ± 8.30</td><td valign="top" align="center">32.41 ± 8.86</td><td valign="top" align="center">0.684b</td></tr><tr><td valign="top" align="left">Education, y</td><td valign="top" align="center">13.85 ± 3.02</td><td valign="top" align="center">13.88 ± 2.79</td><td valign="top" align="center">15.02 ± 2.26</td><td valign="top" align="center">0.053b</td></tr><tr><td valign="top" align="left">Onset age, y</td><td valign="top" align="center">28.03 ± 8.97</td><td valign="top" align="center">28.48 ± 9.29</td><td valign="top" align="center"/><td valign="top" align="center">0.840c</td></tr><tr><td valign="top" align="left">Total illness duration, mo</td><td valign="top" align="center">33.64 ± 53.31</td><td valign="top" align="center">40.50 ± 62.20</td><td valign="top" align="center"/><td valign="top" align="center">0.632c</td></tr><tr><td valign="top" align="left">Current episode duration, mo</td><td valign="top" align="center">7.55 ± 12.81</td><td valign="top" align="center">4.92 ± 4.97</td><td valign="top" align="center"/><td valign="top" align="center">0.279c</td></tr><tr><td valign="top" align="left">Number of episode</td><td valign="top" align="center">1.82 ± 1.26</td><td valign="top" align="center">2.09 ± 1.36</td><td valign="top" align="center"/><td valign="top" align="center">0.400c</td></tr><tr><td valign="top" align="left">Total score of HAMD-17</td><td valign="top" align="center">20.76 ± 9.26</td><td valign="top" align="center">22.27 ± 7.27</td><td valign="top" align="center"/><td valign="top" align="center">0.462c</td></tr><tr><td valign="top" align="left">Family history of AD</td><td valign="top" align="center">1 (3.0%)</td><td valign="top" align="center">4 (12.1%)</td><td valign="top" align="center"/><td valign="top" align="center">0.355a</td></tr><tr><td valign="top" align="left">Chronicity</td><td valign="top" align="center">5 (15.2%)</td><td valign="top" align="center">7 (21.2%)</td><td valign="top" align="center"/><td valign="top" align="center">0.751a</td></tr><tr><td valign="top" align="left">Refractory</td><td valign="top" align="center">3 (9.1%)</td><td valign="top" align="center">3 (9.1%)</td><td valign="top" align="center"/><td valign="top" align="center">1.000a</td></tr><tr><td valign="top" align="left">Suicide attempt</td><td valign="top" align="center">5 (15.2%)</td><td valign="top" align="center">11 (33.3%)</td><td valign="top" align="center"/><td valign="top" align="center">0.150a</td></tr><tr><td valign="top" align="left">Diurnal depression variance</td><td valign="top" align="center">15 (45.5%)</td><td valign="top" align="center">14 (42.4%)</td><td valign="top" align="center"/><td valign="top" align="center">1.000a</td></tr><tr><td valign="top" align="left">Treatment</td><td valign="top" align="center"/><td valign="top" align="center"/><td valign="top" align="center"/><td valign="top" align="center"/></tr><tr><td valign="top" align="left">SSRI/SNRI</td><td valign="top" align="center">20/13</td><td valign="top" align="center">18/15</td><td valign="top" align="center"/><td valign="top" align="center">0.618a</td></tr><tr><td valign="top" align="left">Stabilizer</td><td valign="top" align="center">5 (15.2%)</td><td valign="top" align="center">9 (27.3%)</td><td valign="top" align="center"/><td valign="top" align="center">0.228a</td></tr><tr><td valign="top" align="left">rTMS</td><td valign="top" align="center">4 (12.1%)</td><td valign="top" align="center">4 (12.1%)</td><td valign="top" align="center"/><td valign="top" align="center">1.000a</td></tr><tr><td valign="top" align="left">MECT</td><td valign="top" align="center">4 (12.1%)</td><td valign="top" align="center">6 (18.2%)</td><td valign="top" align="center"/><td valign="top" align="center">0.733a</td></tr></tbody></table></div>UD, unipolar depression; tBD, transformed bipolar depression; HC, health control; HAMD, Hamilton Depression Rating Scale; AD, affective disorder; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and norepinephrine reuptake inhibitor; rTMS, repetitive transcranial magnetic stimulation; MECT, modified electroconvulsive therapy.aThe P-value was obtained by two-tailed Pearson chi-square t-test.bData presented as the range of minimum-maximum (mean ± SD). The P-value was obtained by one-way analysis of variance.cData presented as the range of minimum-maximum (mean ± SD). The P-value was obtained by two-sample two-tailed t-test.</transformed-table></extracted-table></extracted-tables-set>